What is the appropriate management of melena indicating upper gastrointestinal bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Melena (Upper Gastrointestinal Bleeding)

Admit the patient to hospital immediately, initiate resuscitation with intravenous fluids and blood products as needed, start high-dose intravenous proton pump inhibitor therapy (80 mg bolus followed by 8 mg/hour infusion), and perform upper endoscopy within 24 hours for diagnosis and therapeutic intervention. 1

Initial Assessment and Resuscitation

When a patient presents with melena, recognize this as upper gastrointestinal bleeding (UGIB) originating proximal to the ligament of Treitz 2. The priority is immediate hemodynamic assessment:

  • Check vital signs: Shock index (heart rate/systolic BP) >1 indicates hemodynamic instability requiring aggressive resuscitation 3
  • Assess severity markers: Tachycardia (>100 bpm), hypotension (<100 mmHg systolic), or signs of hypovolemia
  • Note that melena alone typically indicates less severe bleeding than hematemesis with melena, but still requires urgent evaluation 2

Resuscitation Protocol

  • Fluid resuscitation: Start with crystalloids to reverse hypovolemia 4
  • Blood transfusion strategy: Use restrictive thresholds
    • Hemoglobin trigger of 70 g/L (target 70-90 g/L) for stable patients
    • Hemoglobin trigger of 80 g/L (target 100 g/L) for patients with cardiovascular disease 3
  • Reverse anticoagulation if present: Use prothrombin complex concentrate and vitamin K for warfarin; interrupt anticoagulation at presentation 3

Pharmacologic Management

Start high-dose intravenous PPI therapy immediately, even before endoscopy 1, 5:

  • Dosing: 80 mg omeprazole bolus, then 8 mg/hour continuous infusion for 72 hours
  • Evidence: This regimen reduces rebleeding and mortality in high-risk patients after endoscopic therapy 5
  • Pre-endoscopy benefit: May downstage lesions and improve endoscopic visualization 1

Do NOT use H2-receptor antagonists - they provide no meaningful benefit and are inferior to PPIs 5

Endoscopic Evaluation and Therapy

Perform upper endoscopy within 24 hours of presentation after initial stabilization 1:

  • Earlier endoscopy (within 12 hours) if hemodynamically unstable or high-risk features present
  • Endoscopy serves dual purpose: Diagnosis of bleeding source and therapeutic intervention

Common Causes to Expect

The most likely diagnoses in order of frequency 2:

  • Peptic ulcer disease (35-50%)
  • Gastroduodenal erosions (8-15%)
  • Mallory-Weiss tears (15%)
  • Esophagitis (5-15%)
  • Varices (5-10%)

Endoscopic Hemostasis

For high-risk stigmata (active bleeding, visible vessel, adherent clot), endoscopic therapy is mandatory 1:

  • Preferred methods: Clips or thermocoagulation, alone or combined with epinephrine injection
  • Never use epinephrine injection alone - it must be combined with mechanical or thermal therapy 1
  • Combination therapy is superior to monotherapy for achieving hemostasis

Post-Endoscopy Management

Monitoring and Hospitalization

  • High-risk patients: Hospitalize for at least 72 hours after successful endoscopic hemostasis 1
  • Continue high-dose PPI infusion for 72 hours, then transition to oral PPI therapy
  • Monitor closely for signs of rebleeding: fresh melena, hematemesis, hemodynamic instability, or hemoglobin drop >20 g/L over 24 hours 2

Management of Rebleeding

If rebleeding occurs 2:

  1. Confirm rebleeding endoscopically - don't assume based on clinical signs alone
  2. Attempt repeat endoscopic therapy once - this is as effective as immediate surgery 2
  3. Consider surgery if:
    • Second rebleed occurs after repeat endoscopic therapy
    • Endoscopic appearances suggest high risk (e.g., giant posterior duodenal ulcer with multiple bleeding points)
    • Patient factors warrant earlier intervention (severe comorbidities, advanced age)

Special Considerations

CT angiography: Reserve for patients who remain hemodynamically unstable despite resuscitation or when endoscopy fails to identify a source 3, 6

Antiplatelet/anticoagulation resumption 1:

  • Restart aspirin when cardiovascular risks outweigh GI risks (usually within 7 days)
  • Use aspirin plus PPI rather than clopidogrel alone to reduce rebleeding risk

Key Pitfalls to Avoid

  • Don't delay endoscopy beyond 24 hours - mortality is lower in units that adhere to protocols 2
  • Don't use epinephrine injection as sole therapy - always combine with mechanical or thermal methods 1
  • Don't perform routine second-look endoscopy - only indicated for selected high-risk patients with suboptimal initial therapy 2
  • Don't rush to surgery - exhaust endoscopic and radiologic options first except in exceptional circumstances 3
  • Don't forget that melena can rarely originate from lower GI sources with slow bleeding, though upper GI is far more common 7

Specialist gastroenterology involvement should occur immediately - mortality is lower when these patients are managed by or in consultation with gastroenterologists 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.